Business Context and Reporting Period
Company: TherapeuticsMD, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 23, 2017
Reporting Period: Fourth quarter and full year ended December 31, 2016.
This filing serves as a notification that the company issued a press release announcing its financial results for the specified period. The detailed results are contained in Exhibit 99.1, which is incorporated by reference.
Key Financial Metrics
The provided text is a cover document for the Form 8-K and does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These figures are located in the referenced press release (Exhibit 99.1) and are not present in the filing text itself.
Material Changes
The filing text does not provide specific details on material changes versus prior periods. It only confirms the announcement of results for the fourth quarter and full year 2016.
Guidance, Outlook, and Risks
- Forward-Looking Statements: The company expressly disclaims any obligation to release publicly any updates or changes in expectations, events, conditions, or circumstances on which forward-looking statements are based.
- Legal Status: Information in this report is furnished pursuant to Item 2.02 and is not deemed "filed" under Section 18 of the Exchange Act. It shall not be incorporated by reference into other filings under the Securities Act or Exchange Act.
- Website Availability: The text notes that the press release is available on the company website but reserves the right to discontinue that availability at any time.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated February 23, 2017) for actual revenue, net income, and cash flow figures.
- Verify the specific details of the fourth quarter and full-year 2016 performance as the 8-K text contains no numerical data.
- Confirm that no forward-looking guidance updates are mandated by this filing due to the explicit disclaimer.